Sofosbuvir-based treatment is safe and effective in patients with chronic hepatitis C infection and end stage renal disease: a case series.
about
Hepatitis C Therapy in Renal Patients: Who, How, When?Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney diseaseEfficacy and safety of sofosbuvir-based regimens in chronic hepatitis C patients on dialysis.Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.Special populations: treating hepatitis C in patients with decompensated cirrhosis and/or advanced renal impairment.Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment.Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis.Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients.Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-based Regimen.Current and future challenges in HCV: insights from an Italian experts panel.Sofosbuvir-based regimens for the treatment of chronic hepatitis C in severe renal dysfunction.The quest for safe and effective treatments of chronic hepatitis C in patients with kidney impairment.Sofosbuvir: A Potential Treatment for EbolaPrevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus
P2860
Q28077130-F0CE62ED-4631-4E71-A4D4-A2759F8EE0A6Q28077263-13940C9F-F91A-4E03-9601-9DBD4691B51CQ33440016-1AE31385-360D-4B0C-8452-603BD0F60910Q36220536-12105C97-75DE-47FF-8F2E-2DD6BAC8C544Q39067369-80A56578-D520-40C8-A545-7C955F18F973Q39092977-FFABEC9A-8B9C-41E7-B22D-BC1ABAB036DCQ40089989-5403D877-32F4-42D4-BB10-07EDF7F524BDQ40604753-2CB0C669-BBC6-4BEB-9BAF-1E27EEAF09F7Q47108436-04114B32-B9A2-4ADC-AEB7-24F3BDDD6BEFQ47591971-9DEC4E63-A13F-447A-8AD6-BCF81C0E5D00Q51754955-3B80F82C-911A-4AD7-A383-49A5310EF4DBQ54597239-522548AB-64FB-4728-8228-458FCDBF1F78Q58576148-FF43FD32-246B-43F9-AA6E-39BC66677F37Q59126211-0493B10F-06DD-4863-ACE1-3C6566985519
P2860
Sofosbuvir-based treatment is safe and effective in patients with chronic hepatitis C infection and end stage renal disease: a case series.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Sofosbuvir-based treatment is ...... renal disease: a case series.
@en
type
label
Sofosbuvir-based treatment is ...... renal disease: a case series.
@en
prefLabel
Sofosbuvir-based treatment is ...... renal disease: a case series.
@en
P2093
P2860
P356
P1433
P1476
Sofosbuvir-based treatment is ...... renal disease: a case series.
@en
P2093
Ibrahim A Hanouneh
John Guirguis
John Rivas
Naim Alkhouri
Sumi Anthony
Tavankit Singh
P2860
P304
P356
10.1111/LIV.13078
P577
2016-01-29T00:00:00Z